Kory James Wentworth, CFO: Entrada Therapeutics TRDA Sell · Filed 03/11

Trade details

Type: Insider sale
Amount: $148,271.76
Shares · price: 11,388 sh · $13.02 a share
Held after: 121,510 sh
Stock: Entrada Therapeutics TRDA
Person: Kory James WentworthCFO
Trade date: 26/03/10
Filed: 26/03/11
Days to filing: 1 days

Sold 8.6% of holdings

Share of holding sold: 8.6%

Entrada Therapeutics trades, last 26 weeks

What else happened in Entrada Therapeutics around then

Filed or reported within 30 days of the trade day · 02/08~04/09

Kory James Wentworth's recent trades

Kory James WentworthCFO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$32.4K
2,500 sh
$32.4K
Filed 04/02
Traded 04/01
Kory James WentworthCFO
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$31.6K
2,500 sh
$31.6K
Filed 04/01
Traded 04/01
Kory James WentworthCFO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$66.2K
5,089 sh
$66.2K
Filed 03/11
Traded 03/09
Kory James WentworthCFO
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$207.3K
16,477 sh
$207.3K
Filed 03/09
Traded 03/09
Kory James WentworthCFO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$97.9K
7,988 sh
$97.9K
Filed 03/06
Traded 03/04

Kory James Wentworth, CFO — sold $148.3K of Entrada Therapeutics TRDA · 8.6% of holdings · 10b5-1 plan | Whalegun